
Tirzepatide 5mg Vial
$95.00
Tirzepatide 5mg lyophilized vial for metabolic research applications. Purity ≥99% verified by HPLC and mass spectrometry. Batch-specific Certificate of Analysis included. Dual GIP/GLP-1 receptor agonist for weight-management studies. View full Tirzepatide compound profile.
Description
Tirzepatide 5mg Lyophilized Research Vial
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. With a molecular weight of approximately 4813.5 Da and CAS number 2023788-19-2, tirzepatide represents a new class of dual-incretin peptides studied for their effects on metabolic regulation and energy balance. This 5mg lyophilized vial is suited for standard research protocols.
Product Specifications
- Quantity: 5 mg per vial
- Form: Lyophilized (freeze-dried) powder
- Purity: ≥99% by HPLC
- CAS: 2023788-19-2
- Molecular Weight: ~4813.5 Da
Quality Assurance
All tirzepatide batches undergo HPLC and mass spectrometry (MS) verification for identity and purity. A batch-specific Certificate of Analysis (COA) is provided with every order. See our testing protocols and COA guide.
Storage & Handling
Store lyophilized tirzepatide at -20°C for maximum shelf life. After reconstitution, hold at 2-8°C and use within 14 days. Protect from light. Refer to our peptide storage and shipping guide.
Wholesale & Bulk Pricing
Wholesale pricing available for qualified research buyers and distributors. See our Tirzepatide wholesale page or apply to the wholesale program. Also available in 10mg vial format.
Browse our Weight Management catalog.
For laboratory research use only. Not for human consumption.
Reviews
There are no reviews yet.